| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGX | Common Stock | Sale | -$69.9K | -500 | -100% | $139.89 | 0 | Dec 23, 2024 | Held in The David and Laura Watson Foundation | |
| transaction | AGX | Common Stock | Options Exercise | $0 | +1.86K | +3.65% | $0.00 | 52.6K | Apr 16, 2025 | Direct | F1 |
| transaction | AGX | Common Stock | Options Exercise | $0 | +2.29K | +4.34% | $0.00 | 54.9K | Apr 17, 2025 | Direct | F2 |
| transaction | AGX | Common Stock | Options Exercise | $0 | +1.96K | +3.56% | $0.00 | 56.9K | Apr 18, 2025 | Direct | F3 |
| transaction | AGX | Common Stock | Options Exercise | $0 | +11.7K | +20.64% | $0.00 | 68.6K | Apr 18, 2025 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGX | Time-Based Restricted Stock Units | Options Exercise | $0 | -3.33K | -15.62% | $0.00 | 18K | Apr 16, 2025 | Common Stock | 3.33K | $0.00 | Direct | F1 |
| transaction | AGX | Time-Based Restricted Stock Units | Award | $0 | +4K | +22.22% | $0.00 | 22K | Apr 16, 2025 | Common Stock | 4K | $0.00 | Direct | F5 |
| transaction | AGX | Option to Purchase Common Stock | Award | $0 | +2K | +17.65% | $0.00 | 13.3K | Apr 16, 2025 | Common Stock | 2K | $148.72 | Direct | F6 |
| transaction | AGX | Performance-Based Restricted Stock Units | Award | $0 | +3K | +15.79% | $0.00 | 22K | Apr 16, 2025 | Common Stock | 3K | $0.00 | Direct | F7 |
| transaction | AGX | Earnings Per Share Performance-Based Restricted Stock Units | Award | $0 | +7.5K | +41.67% | $0.00 | 25.5K | Apr 16, 2025 | Common Stock | 7.5K | $0.00 | Direct | F8 |
| transaction | AGX | Time-Based Restricted Stock Units | Options Exercise | $0 | -4K | -18.18% | $0.00 | 18K | Apr 17, 2025 | Common Stock | 4K | $0.00 | Direct | F2 |
| transaction | AGX | Time-Based Restricted Stock Units | Options Exercise | $0 | -3.33K | -18.52% | $0.00 | 14.7K | Apr 18, 2025 | Common Stock | 3.33K | $0.00 | Direct | F3 |
| transaction | AGX | Performance-Based Restricted Stock Units | Options Exercise | $0 | -10K | -45.45% | $0.00 | 12K | Apr 18, 2025 | Common Stock | 10K | $0.00 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. |
| F2 | Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. |
| F3 | Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025. |
| F4 | Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000. |
| F5 | On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026. |
| F6 | On April 16, 2025, the Reporting Person received 10-year options to purchase 2,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026. |
| F7 | On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. |
| F8 | On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. |